Einloggen

Thematische Bibliographien / Treatment of tobacco dependance / Zeitschriftenartikel

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Treatment of tobacco dependance.

Zeitschriftenartikel zum Thema „Treatment of tobacco dependance“

Autor: Grafiati

Veröffentlicht am 28. Juni 2021

Zuletzt aktualisiert am 1. Februar 2022

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Treatment of tobacco dependance" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Nespoulous, C., P. Fabisch, A. Radunz und G. H. Schmid. „Immunological Study on the Structural Difference between Ribulose- 1,5-bisphosphate Carboxylase/Oxygenase from Nicotiana tabacum var. John William's Broadleaf and the Tobacco Mutant Su/su“. Zeitschrift für Naturforschung C 43, Nr. 9-10 (01.10.1988): 717–26. http://dx.doi.org/10.1515/znc-1988-9-1014.

Der volle Inhalt der Quelle

Annotation:

Abstract In the present paper we have attempted to characterize by means of immunological methods the molecular difference between ribulose 1,5-bisphosphate carboxylase/oxygenase from the wild type TV. tabacum var. John William's Broadleaf and the tobacco mutant Su/su. The tobacco mutant Su/su exhibits in comparison to the wild type a higher photorespiratory activity. The reagents used in the present study are monospecific antisera to the two bifunctional enzymes to be compared. We have analyzed the oxygenase activity of the two enzymes in dependance on the binding of the amount of antibodies out of the homologous and the not homologous antiserum. These analyses have shown, that the enzymes of both phenotypes were 4 0 % stronger inhibited in the equivalence regions with respect to their oxygenase function by antibodies of the antiserum to ribulose 1,5-bisphosphate carboxylase/oxygenase of the mutant than by antibodies of the wild type antiserum. It should be noted that the antiserum to the mutant enzyme exhibits a 25 % lower antibody titer, than the antiserum to the wild type enzyme. In the region of extreme antibody excess, i.e. when antibodies are mostly monovalently bound and most antigenic determinants are saturated with antibodies, the oxygenase activity of both enzymes decreases towards zero in the presence of the homologous as well as in the presence of non-homologous antibodies. In the region of excess of antigenic determinants, that is when only a few antibody molecules can bind onto the enzymes, only the oxygenase activity of the mutant enzyme is inhibited by its homologous antibodies by 40 % . This apparent difference in the molecular structure of the two bifunctional enzymes to be compared is neither caught in the double immuno diffussion test nor in the tandem crossed immuno electrophoresis, using the two antisera as test reagents. In all cases only fused precipitation bands are observed. Chemical modification of ribulose 1,5-bisphosphate carboxylase/oxygenase by hydroxylamine treatment or treatment with o-(p-nitrophenyl)hydroxylamine or simple heating of the enzyme to 50 °C are immunologically characterized. As a consequence of such treatment considerably less antibodies are adsorbed. The strongest influence exerts a treatment with o-(p-nitrophenyl)-hydroxylamine with simultaneous heat treatment of the enzyme for 20 min at 50 °C.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Lansdell, M. „15 years of practical sewage treatment in Venezuela“. Water Science and Technology 33, Nr. 3 (01.02.1996): 39–46. http://dx.doi.org/10.2166/wst.1996.0057.

Der volle Inhalt der Quelle

Annotation:

A summary of fifteen years of experience of the design, operation and performance several Venezuelan municipal wastewater treatment systems to serve a population of 5 million is presented. Technical and institutional problems which occurred during construction and operation are described and some of the solutions are presented. It was found that the most simple systems were the most effective and that it was important to develop solutions appropriate to local needs and avoid the technological dependance on imported spare parts.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Sachs, David P. L. „Tobacco Dependence Treatment“. Chest 129, Nr. 4 (April 2006): 836–39. http://dx.doi.org/10.1378/chest.129.4.836.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Rajaram, Prashanth, Poornima C., Poornima G. und Shruthi R. „Treatment of Tobacco Dependence“. Indian Journal of Contemporary Dentistry 1, Nr. 1 (2013): 53. http://dx.doi.org/10.5958/j.2320-5962.1.1.015.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Burke, Michael V., Jon O. Ebbert und J. Taylor Hays. „Treatment of Tobacco Dependence“. Mayo Clinic Proceedings 83, Nr. 4 (April 2008): 479–84. http://dx.doi.org/10.4065/83.4.479.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Kathuria, Hasmeena, Frank T. Leone und Enid R. Neptune. „Treatment of tobacco dependence“. Current Opinion in Pulmonary Medicine 24, Nr. 4 (Juli 2018): 327–34. http://dx.doi.org/10.1097/mcp.0000000000000491.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

OʼBRIEN, MAUREEN. „Certification in Tobacco Treatment“. Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 25, Nr. 3 (März 2007): 162–66. http://dx.doi.org/10.1097/01.nhh.0000263433.85190.02.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Fiore, Michael C. „Effective Tobacco Dependence Treatment“. JAMA 288, Nr. 14 (09.10.2002): 1768. http://dx.doi.org/10.1001/jama.288.14.1768.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Chaibi, P., N. Magne, S. Breton, A. Chebib, J. Duron, M. Tagzirt, L. Hannoun, F. Piette, D. Khayat und J. Spano. „Influence of geriatric consultation with Comprehensive Geriatric Assessment (CGA) on therapeutic decision in elderly cancer patients“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 9505. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.9505.

Der volle Inhalt der Quelle

Annotation:

9505 Background: Elderly patients represent an heterogeneous population in which anticancer therapeutic decision is often difficult and may be helped by CGA. We report 2 years activity of the geriatric assessment consultation of our institution, and its impact on therapeutic decision Methods: Since January 2007, we propose a geriatric consultation for elderly cancer patients for whom therapeutic decision appears complex to oncologists. This consultation included a CGA, with focuses on items like comorbidity, dependance, cognitive impairment, depression and malnutrition using international well known scales. Results: 161 patients (57 men, 104 women) (median age 82,4 years, extremes 73 -97) were seen at the geriatric consultation. Most of the patients (134/161) were in fist line treatment for colorectal (54), other digestive (28), breast (30) and pulmonary (14) cancers. Cancer was metastatic in 86 patients (53 %). Geriatric assessment found: severe comorbidity (grade 3 or 4 in CIRS-G scale) in 75 patients, dependance for at least one activity of daily living (ADL) in 52 patients, cognitive impairment in 42 patients, including 13 patients with already diagnosed Alzheimer disease, malnutrition in 104 patients (65 %), depression in 39 patients. According to prior oncologist decision, there have been no change in therapeutic decision in 29 patients only. Geriatric interventional treatment was delivered to 122 patients (76 %). Anticancer treatment was changed in 79 patients (49 %), including delayed therapy in 5 patients, less intensive therapy in 29 patients and more intensive therapy in 45 patients. Patients for whom final decision was delayed or less intensive therapy had significantly more frequent severe comorbidity (23/34, p < 0.01) and dependance for at least one ADL (19/34, p < 0.01). Patients for whom final decision was more intensive therapy had significantly more frequent metastatic disease (33/45, p < 0.01) Conclusions: Geriatric evaluation did influence therapeutic decision in 82 % of the patients. Follow up data will be presented to evaluate quality of final therapeutic decision, especially data concerning dose intensity and toxicity for patients with a more intensive therapy final decision. No significant financial relationships to disclose.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Finlayson, A. J. Reid. „The Tobacco Dependence Treatment Handbook“. Journal of Clinical Psychiatry 65, Nr. 5 (15.05.2004): 727–28. http://dx.doi.org/10.4088/jcp.v65n0521b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Pbert, Lori, Jane Zapka, Denise G. Jolicoeur, Mary Jo White, Karin Valentine Goins, George Reed und Judith K. Ockene. „Implementing State Tobacco Treatment Services“. Health Promotion Practice 12, Nr. 6 (13.05.2011): 802–10. http://dx.doi.org/10.1177/1524839910376035.

Der volle Inhalt der Quelle

Annotation:

This case study was conducted between 2000 and 2003 to examine the implementation of community based tobacco treatment programs funded by the Massachusetts Department of Public Health Tobacco Control Program (MTCP). Four dimensions of implementation, drawn from several models of program evaluation are explored: (a) quantity of services, (b) quality of services, (c) implementation/use of systems, and (d) sustainability. The quantity of services delivered was high, reflecting MTCP’s focus on increasing availability of services, particularly in underserved populations. The quality of physician-delivered tobacco intervention did not meet national benchmarks for delivery of all 5As (Ask, Advise, Assess, Assist, Arrange follow-up) and only about half of organizations reported routine systems for auditing tobacco use documentation. Implementation of systems to identify tobacco users and deliver tobacco treatment varied widely by community health settings, with low rates of tobacco use documentation found. Finally, in an era of greater competition for scarce prevention dollars, sustainability of services over time must be planned for from the outset, as indicated by the success of programs that sustained services by proactively and creatively incorporating tobacco treatment into their organizations. This case study can inform states’ policies in their design of tobacco treatment services in community health settings.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Lewith, G. T. „The treatment of tobacco addiction“. Complementary Therapies in Medicine 3, Nr. 3 (Juli 1995): 142–45. http://dx.doi.org/10.1016/s0965-2299(95)80054-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Berlin, Ivan, Jean Perriot und François Letourmy. „Tobacco Treatment Specialists in France“. Journal of Smoking Cessation 4, Nr. 2 (01.12.2009): 102–3. http://dx.doi.org/10.1375/jsc.4.2.102.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Folan, Patricia A., Harlan R. Juster, Susan E. Lennon, Patricia J. Briest und C. Beth Gero. „Improving Tobacco Dependence Treatment Delivery“. American Journal of Preventive Medicine 49, Nr. 2 (August 2015): e9-e12. http://dx.doi.org/10.1016/j.amepre.2015.04.005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Harris, Debra S., und Robert M. Anthenelli. „Expanding treatment of tobacco dependence“. Current Psychiatry Reports 7, Nr. 5 (September 2005): 344–51. http://dx.doi.org/10.1007/s11920-005-0034-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Jarvik, Murray E., und Jack E. Henningfield. „Pharmacological treatment of tobacco dependence“. Pharmacology Biochemistry and Behavior 30, Nr. 1 (Mai 1988): 279–94. http://dx.doi.org/10.1016/0091-3057(88)90456-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Carlini, Beatriz H., Susan M. Zbikowski, Harold S. Javitz, T. Mona Deprey, Sharon E. Cummins und Shu-Hong Zhu. „Telephone-Based Tobacco-Cessation Treatment“. American Journal of Preventive Medicine 35, Nr. 1 (Juli 2008): 73–76. http://dx.doi.org/10.1016/j.amepre.2008.03.025.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Hunt, Jamie J., A. Paula Cupertino, Susan Garrett, Peter D. Friedmann und Kimber P. Richter. „How is tobacco treatment provided during drug treatment?“ Journal of Substance Abuse Treatment 42, Nr. 1 (Januar 2012): 4–15. http://dx.doi.org/10.1016/j.jsat.2011.06.007.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Beslic, Nermina, Sabrina Licina, Amera Sadija und Renata Milardovic. „Incidence of Hypothyreoidism after Radioactive Iodine-I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose“. Medical Archives 71, Nr. 4 (2017): 270. http://dx.doi.org/10.5455/medarh.2017.71.270-273.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Guydish, Joseph, Kwinoja Kapiteni, Thao Le, Barbara Campbell, Erika Pinsker und Kevin Delucchi. „Tobacco use and tobacco services in California substance use treatment programs“. Drug and Alcohol Dependence 214 (September 2020): 108173. http://dx.doi.org/10.1016/j.drugalcdep.2020.108173.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Perka, Edward J. „Culture Change in Addictions Treatment“. Health Promotion Practice 12, Nr. 6_suppl_2 (November 2011): 159S—165S. http://dx.doi.org/10.1177/1524839911414410.

Der volle Inhalt der Quelle

Annotation:

Targeted training and technical assistance can have a major impact on the attitudes and beliefs of addiction service providers with respect to the treatment of tobacco dependency. Major gains have been made with the general public since the mid-1960s with respect to the reduction of tobacco use behavior and tobacco-related diseases. Tobacco use continues to be a major public health problem, and tobacco control initiatives are significantly affecting public attitudes and norms regarding tobacco use. There is, however, a specific population that has not benefited from these gains and, in fact, has been encouraged to continue smoking rather than make an attempt to quit. Individuals with a substance use disorder and/or mental health disorder have a much higher percentage of tobacco use than the general population, resulting in major health disparities. The addiction treatment and recovery community has lagged behind the general public in addressing tobacco use. New York State’s project, “Integrating Tobacco Use Interventions Into Chemical Dependence Services,” is a model that demonstrates how innovative regulations, and training and technical assistance developed specifically for addiction service providers, can initiate culture change with respect to tobacco use within addiction treatment settings, resulting in improved treatment outcomes and longer term stable recovery.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

McDaniel, Anna M., Renee M. Stratton und Maria Britain. „Systems Approaches to Tobacco Dependence Treatment“. Annual Review of Nursing Research 27, Nr. 1 (Dezember 2009): 345–63. http://dx.doi.org/10.1891/0739-6686.27.345.

Der volle Inhalt der Quelle

Annotation:

Nurses have been at the forefront of initiatives to improve patient outcomes through systems change. Nursing research addressing systems approaches to treatment of tobacco dependence has demonstrated increased implementation of evidence-based practice guidelines. Existing health system research conducted by nurse scientists has focused on four strategies: tobacco use identification systems, education and training of nursing staff to deliver tobacco intervention, dedicated staff for tobacco dependence treatment in both acute and primary care settings, and institutional policies to support tobacco intervention. Nursing involvement in multidisciplinary health services research focusing on tobacco treatment has lagged behind advances in clinical nursing research of individual-focused smoking cessation interventions. Health information technology shows promise as part of an integrated approach to systems changes to support tobacco intervention, particularly in light of the current national emphasis on adoption and meaningful use of electronic health records. Future directions for translational research present unprecedented opportunity for nurse scientists to respond to the call for policy and systems changes to support tobacco treatment.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Leone, Frank T., Sarah Evers-Casey, Mary A. Mulholland und David P. L. Sachs. „Integrating Tobacco Use Treatment Into Practice“. Chest 149, Nr. 2 (Februar 2016): 568–75. http://dx.doi.org/10.1378/chest.15-0441.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Rigotti, Nancy A. „Treatment of Tobacco Use and Dependence“. New England Journal of Medicine 346, Nr. 7 (14.02.2002): 506–12. http://dx.doi.org/10.1056/nejmcp012279.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Williams, Jill M., und Jonathan Foulds. „Successful Tobacco Dependence Treatment in Schizophrenia“. American Journal of Psychiatry 164, Nr. 2 (Februar 2007): 222–27. http://dx.doi.org/10.1176/ajp.2007.164.2.222.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Hughes, John R. „Tobacco Treatment Specialists: A New Profession“. Journal of Smoking Cessation 2, S1 (01.12.2007): 2–7. http://dx.doi.org/10.1375/jsc.2.supp.2.

Der volle Inhalt der Quelle

Annotation:

AbstractTobacco treatment specialists (TTS) are essential to developing an adequate system of treatment for smoking. Tobacco cessation treatment should be seen, not solely as a public health or prevention activity, but rather as a clinical activity. TTS should increase their professionalism by embracing evidence-based medicine. TTS should form professional organizations and credentialing bodies to insure a high quality professional identity.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Thun, M. „Improving the treatment of tobacco dependence“. BMJ 321, Nr. 7257 (05.08.2000): 311–12. http://dx.doi.org/10.1136/bmj.321.7257.311.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Sachs, D. P. L., und N. L. Benowitz. „Individualizing medical treatment for tobacco dependence“. European Respiratory Journal 9, Nr. 4 (01.04.1996): 629–31. http://dx.doi.org/10.1183/09031936.96.09040629.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Shelley, Donna, Deanna Jannat-Khah und Mark Wolff. „Tobacco-use treatment in dental practice“. Journal of the American Dental Association 142, Nr. 6 (Juni 2011): 592–96. http://dx.doi.org/10.14219/jada.archive.2011.0229.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Miranda, John. „Tobacco use in the treatment trenches“. Alcoholism & Drug Abuse Weekly 32, Nr. 17 (24.04.2020): 5–6. http://dx.doi.org/10.1002/adaw.32702.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Hughes, John R. „Treatment Regulation in Promoting Tobacco Control“. JAMA 299, Nr. 7 (20.02.2008): 763. http://dx.doi.org/10.1001/jama.299.7.763-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Berlin, Ivan. „Comorbidities and Tobacco Dependence Treatment Initiation“. Nicotine & Tobacco Research 18, Nr. 8 (24.02.2016): 1683. http://dx.doi.org/10.1093/ntr/ntw039.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Sarna, Linda. „Resources for Treatment of Tobacco Dependency“. Cancer Practice 8, Nr. 5 (September 2000): 248–53. http://dx.doi.org/10.1046/j.1523-5394.2000.85009.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Kalkhoran, Sara, Neal L. Benowitz und Nancy A. Rigotti. „Prevention and Treatment of Tobacco Use“. Journal of the American College of Cardiology 72, Nr. 9 (August 2018): 1030–45. http://dx.doi.org/10.1016/j.jacc.2018.06.036.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Shorstky, I. A., M. D. Sosnin, E. V. Gnuchikh und E. E. Ulyanchenko. „Microplasma treatment for tobacco leaves drying“. Processes and Food Production Equipment 14, Nr. 1 (2021): 25–33. http://dx.doi.org/10.17586/2310-1164-2021-14-1-25-33.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Sheffer, Christine E., Thomas Payne, Jamie S. Ostroff, Denise Jolicoeur, Michael Steinberg, Sharon Czabafy, Jonathan Foulds, Matthew Bars, Ken Wassum und Barbara Perry. „Increasing the Quality and Availability of Evidence-based Treatment for Tobacco Dependence through Unified Certification of Tobacco Treatment Specialists“. Journal of Smoking Cessation 11, Nr. 4 (30.12.2014): 229–35. http://dx.doi.org/10.1017/jsc.2014.30.

Der volle Inhalt der Quelle

Annotation:

Each year, tobacco use causes over 6 million deaths and is responsible for hundreds of billions of dollars in health care and economic costs in the world (WHO, 2011). If current trends continue, tobacco is expected to kill over 1 billion people in the 21st century, making it one of the single greatest causes of preventable death and disease in history (WHO, 2011). Long-term abstinence from tobacco use dramatically improves individuals’ health, reduces the incidence of tobacco-related disease, and is clearly responsible for saving lives (Anthonisen et al., 2005). Most tobacco users express a desire to achieve long-term abstinence from tobacco use and make numerous unsuccessful quit attempts over the course of many years (Borland, Partos, Yong, Cummings, & Hyland, 2012; CDC, 2011). Evidence-based treatments for tobacco use and dependence greatly improve the chances that quit attempts result in long-term abstinence (Chambless & Hollon, 1998; Chambless et al., 1998; Compas, Haaga, Keefe, Leitenberg, & Williams, 1998; Fiore et al., 2008; Zwar et al., 2004). Increasing the availability of high-quality evidence-based treatment for tobacco use and dependence will make it more likely that tobacco users use evidence-based treatments and that quit attempts translate into long-term abstinence. The professionalisation of treatment for tobacco dependence by the development of a rigorous, unified Tobacco Treatment Specialist (TTS) certification process will increase the availability of high-quality evidence-based treatment for tobacco use and dependence for all tobacco users.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

WILLIAMS, J., J. FOULDS, M. DWYER, B. ORDERCONNORS, M. SPRINGER, P. GADDE und D. ZIEDONIS. „The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey“. Journal of Substance Abuse Treatment 28, Nr. 4 (Juni 2005): 331–40. http://dx.doi.org/10.1016/j.jsat.2005.02.010.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Friend, Karen B., und David T. Levy. „Adoption of Tobacco Treatment Interventions by Substance-abuse-treatment Clinicians“. Drugs: Education, Prevention and Policy 11, Nr. 1 (Februar 2004): 1–20. http://dx.doi.org/10.1080/0968763031000105038.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Enyioha, Chineme, Graham W. Warren, Glen D. Morgan und Adam O. Goldstein. „Tobacco Use and Treatment among Cancer Survivors“. International Journal of Environmental Research and Public Health 17, Nr. 23 (06.12.2020): 9109. http://dx.doi.org/10.3390/ijerph17239109.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Hays, J. Taylor, und Jon O. Ebbert. „Bupropion for the Treatment of Tobacco Dependence“. CNS Drugs 17, Nr. 2 (2003): 71–83. http://dx.doi.org/10.2165/00023210-200317020-00001.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Fertig, Joanne B. „Overview-Alcohol and Tobacco: Mechanisms and Treatment“. Alcoholism: Clinical and Experimental Research 26, Nr. 12 (Dezember 2002): 1909–10. http://dx.doi.org/10.1111/j.1530-0277.2002.tb02499.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Sobell, Mark B. „Alcohol and Tobacco: Clinical and Treatment Issues“. Alcoholism: Clinical and Experimental Research 26, Nr. 12 (Dezember 2002): 1954–55. http://dx.doi.org/10.1111/j.1530-0277.2002.tb02517.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

SARNA, LINDA, STELLA A. BIALOUS, VIRGINIA H. RICE und MARY ELLEN WEWERS. „Promoting tobacco dependence treatment in nursing education“. Drug and Alcohol Review 28, Nr. 5 (02.09.2009): 507–16. http://dx.doi.org/10.1111/j.1465-3362.2009.00107.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Mann, Lee S., Robert W. Johnson und Daniel J. Levine. „Tobacco dependence: Psychology, biology, and treatment strategies“. Psychosomatics 27, Nr. 10 (Oktober 1986): 713–18. http://dx.doi.org/10.1016/s0033-3182(86)72621-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Wewers, Mary Ellen, Linda Sarna und Virginia Hill Rice. „Nursing Research and Treatment of Tobacco Dependence“. Nursing Research 55, Supplement 1 (Juli 2006): S11—S15. http://dx.doi.org/10.1097/00006199-200607001-00003.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Leone, Frank T., Sarah Evers-Casey, Benjamin A. Toll und Anil Vachani. „Treatment of Tobacco Use in Lung Cancer“. Chest 143, Nr. 5 (Mai 2013): e61S-e77S. http://dx.doi.org/10.1378/chest.12-2349.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Hatsukami, Dorothy K., Joni Jensen, Raymond Boyle, Michael Grillo und Robin Bliss. „Characteristics of smokeless tobacco users seeking treatment“. Addictive Behaviors 24, Nr. 4 (Juli 1999): 551–57. http://dx.doi.org/10.1016/s0306-4603(98)00092-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Raw, Martin, Judith Mackay und Srinath Reddy. „Time to take tobacco dependence treatment seriously“. Lancet 387, Nr. 10017 (Januar 2016): 412–13. http://dx.doi.org/10.1016/s0140-6736(15)00950-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Warnakulasuriya, Saman, Gay Sutherland und Crispian Scully. „Tobacco, oral cancer, and treatment of dependence“. Oral Oncology 41, Nr. 3 (März 2005): 244–60. http://dx.doi.org/10.1016/j.oraloncology.2004.08.010.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Zaparoli, Juçara Xavier, und José Carlos Fernandes Galduróz. „Treatment for tobacco smoking: A new alternative?“ Medical Hypotheses 79, Nr. 6 (Dezember 2012): 867–68. http://dx.doi.org/10.1016/j.mehy.2012.09.009.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!